%0 Journal Article %1 Tischer_Zimmermann_2023 %A Tischer-Zimmermann, S %A Bonifacius, A %A Santamorena, M M %A Mausberg, P %A Stoll, S %A Döring, M %A Kalinke, U %A Blasczyk, R %A Maecker-Kolhoff, B %A Eiz-Vesper, B %D 2023 %I Frontiers Media SA %J Front Immunol %K kalinke %P 878953 %R 10.3389/fimmu.2023.878953 %T Reinforcement of cell-mediated immunity driven by tumor-associated Epstein-Barr virus (EBV)-specific T cells during targeted B-cell therapy with rituximab %U https://pubmed.ncbi.nlm.nih.gov/37033971/ %V 14

@article{Tischer_Zimmermann_2023, added-at = {2023-05-03T09:43:00.000+0200}, author = {Tischer-Zimmermann, S and Bonifacius, A and Santamorena, M M and Mausberg, P and Stoll, S and Döring, M and Kalinke, U and Blasczyk, R and Maecker-Kolhoff, B and Eiz-Vesper, B}, biburl = {https://www.bibsonomy.org/bibtex/2f24e4cecbceacc5a49c07e19dc455b31/kalinke}, doi = {10.3389/fimmu.2023.878953}, interhash = {eaf3bb8ca242209fe5194ffc8d2f235c}, intrahash = {f24e4cecbceacc5a49c07e19dc455b31}, journal = {Front Immunol}, keywords = {kalinke}, month = mar, pages = 878953, publisher = {Frontiers Media {SA}}, timestamp = {2023-05-03T09:43:00.000+0200}, title = {Reinforcement of cell-mediated immunity driven by tumor-associated Epstein-Barr virus (EBV)-specific T cells during targeted B-cell therapy with rituximab}, url = {https://pubmed.ncbi.nlm.nih.gov/37033971/}, volume = 14, year = 2023 }